Advertisement
Review Article|Articles in Press

Glucose Counterregulation

Clinical Consequences of Impaired Sympathetic Responses in Diabetic Dogs and Cats
Published:March 08, 2023DOI:https://doi.org/10.1016/j.cvsm.2023.01.001

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fleeman L.M.
        • Rand J.S.
        Management of canine diabetes.
        Vet Clin North Am Small Anim Pract. 2001; 31 (vi): 855-880
        • Nelson R.W.
        Canine diabetes mellitus.
        in: Feldman E. Nelson R.W. Canine and feline endocrinology. 4th edition. Saunders, Philadelphia, PA2015: 213-257
        • Cryer P.E.
        The barrier of hypoglycemia in diabetes.
        Diabetes. 2008; 57: 3169-3176
        • Bolli G.
        • de Feo P.
        • Compagnucci P.
        • et al.
        Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
        Diabetes. 1983; 32: 134-141
        • Gerich J.E.
        • Langlois M.
        • Noacco C.
        • et al.
        Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.
        Science. 1973; 182: 171-173
        • Taborsky G.J.
        • Mundinger T.O.
        Minireview: The Role of the Autonomic Nervous System in Mediating the Glucagon Response to Hypoglycemia.
        Endocrinology. 2012; 153: 1055-1062
        • Niessen S.J.M.
        • Powney S.
        • Guitian J.
        • et al.
        Evaluation of a quality-of-life tool for cats with diabetes mellitus.
        J Vet Intern Med. 2010; 24: 1098-1105
        • Niessen S.J.M.
        • Powney S.
        • Guitian J.
        • et al.
        Evaluation of a Quality-of-Life Tool for Dogs with Diabetes Mellitus.
        J Vet Intern Med. 2012; 26: 953-961
        • Nelson R.W.
        • Lynn R.C.
        • Wagner-Mann C.C.
        • et al.
        Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
        J Am Vet Med Assoc. 2001; 218: 38-42
        • Zini E.
        • Salesov E.
        • Dupont P.
        • et al.
        Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats.
        J Vet Intern Med. 2018; 32: 978-985
        • Nelson R.W.
        • Henley K.
        • Cole C.
        Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
        J Vet Intern Med. 2009; 23: 787-793
        • Roomp K.
        • Rand J.
        Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine.
        J Feline Med Surg. 2009; 11: 668-682
        • Fracassi F.
        • Corradini S.
        • Hafner M.
        • et al.
        Detemir insulin for the treatment of diabetes mellitus in dogs.
        J Am Vet Med Assoc. 2015; 247: 73-78
        • Monroe W.E.
        • Laxton D.
        • Fallin E.A.
        • et al.
        Efficacy and safety of a purified porcine insulin zinc suspension for managing diabetes mellitus in dogs.
        J Vet Intern Med. 2005; 19: 675-682
        • Ward C.R.
        • Christiansen K.
        • Li J.
        • et al.
        Field efficacy and safety of protamine zinc recombinant human insulin in 276 dogs with diabetes mellitus.
        Domest Anim Endocrinol. 2021; 75: 106575
        • Roomp K.
        • Rand J.
        Rebound hyperglycaemia in diabetic cats.
        J Feline Med Surg. 2016; 18: 587-596
        • Marshall R.D.
        • Rand J.S.
        • Morton J.M.
        Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
        J Feline Med Surg. 2009; 11: 683-691
        • Viebrock K.A.
        • Dennis J.
        Hypoglycemic episodes in cats with diabetes mellitus: 30 cases (2013-2015).
        J Feline Med Surg. 2018; 20: 563-570
        • Mori A.
        • Kurishima M.
        • Oda H.
        • et al.
        Comparison of glucose fluctuations between day- and night-time measured using a continuous glucose monitoring system in diabetic dogs.
        J Vet Med Sci. 2013; 75: 113-117
        • Shea E.K.
        • Hess R.S.
        Assessment of postprandial hyperglycemia and circadian fluctuation of glucose concentrations in diabetic dogs using a flash glucose monitoring system.
        J Vet Intern Med. 2021; 35: 843-852
        • della Maggiore A.
        • Nelson R.W.
        • Dennis J.
        • et al.
        Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus.
        J Vet Intern Med. 2012; 26: 109-115
        • Workgroup on Hypoglycemia, American Diabetes Association
        Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.
        Diabetes Care. 2005; 28: 1245-1249
        • DeClue A.E.
        • Cohn L.A.
        • Kerl M.E.
        • et al.
        Use of continuous blood glucose monitoring for animals with diabetes mellitus.
        J Am Anim Hosp Assoc. 2004; 40: 171-173
        • Casella M.
        • Hässig M.
        • Reusch C.E.
        Home-monitoring of blood glucose in cats with diabetes mellitus: evaluation over a 4-month period.
        J Feline Med Surg. 2005; 7: 163-171
        • Casella M.
        • Wess G.
        • Hässig M.
        • et al.
        Home monitoring of blood glucose concentration by owners of diabetic dogs.
        J Small Anim Pract. 2003; 44: 298-305
        • Zick R.
        • Petersen B.
        • Richter M.
        • et al.
        Comparison of Continuous Blood Glucose Measurement with Conventional Documentation of Hypoglycemia in Patients with Type 2 Diabetes on Multiple Daily Insulin Injection Therapy.
        Diabetes Technol Ther. 2007; 9: 483-492
        • Pazos-Couselo M.
        • García-López J.M.
        • González-Rodríguez M.
        • et al.
        High Incidence of Hypoglycemia in Stable Insulin-Treated Type 2 Diabetes Mellitus: Continuous Glucose Monitoring vs. Self-Monitored Blood Glucose. Observational Prospective Study.
        Can J Diabetes. 2015; 39: 428-433
        • del Baldo F.
        • Canton C.
        • Testa S.
        • et al.
        Comparison between a flash glucose monitoring system and a portable blood glucose meter for monitoring dogs with diabetes mellitus.
        J Vet Intern Med. 2020; 34: 2296-2305
        • Idowu O.
        • Heading K.
        Hypoglycemia in dogs: Causes, management, and diagnosis.
        Can Vet J. 2018; 59: 642-649
        • Sankar A.
        • Khodai T.
        • McNeilly A.D.
        • et al.
        Experimental Models of Impaired Hypoglycaemia-Associated Counter-Regulation.
        Trends Endocrinol Metab. 2020; 31: 691-703
        • Whitley N.T.
        • Drobatz K.J.
        • Panciera D.L.
        Insulin overdose in dogs and cats: 28 cases (1986-1993).
        J Am Vet Med Assoc. 1997; 211: 326-330
        • Little C.J.L.
        Hypoglycaemic bradycardia and circulatory collapse in a dog and a cat.
        J Small Anim Pract. 2005; 46: 445-448
        • Zhou H.
        • Tran P.O.T.
        • Yang S.
        • et al.
        Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: the “switch-off” hypothesis.
        Diabetes. 2004; 53: 1482-1487
        • Rizza R.A.
        • Cryer P.E.
        • Gerich J.E.
        Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation.
        J Clin Invest. 1979; 64: 62-71
        • Banarer S.
        • McGregor V.P.
        • Cryer P.E.
        Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response.
        Diabetes. 2002; 51: 958-965
        • Sherck S.M.
        • Shiota M.
        • Saccomando J.
        • et al.
        Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural input.
        Diabetes. 2001; 50: 2487-2496
        • Havel P.J.
        • Taborsky G.J.
        The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress.
        Endocr Rev. 1989; 10: 332-350
        • Havel P.J.
        • Akpan J.O.
        • Curry D.L.
        • et al.
        Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglucopenia and hypoglycemia in mice.
        Am J Physiol. 1993; 265: R246-R254
        • Havel P.J.
        • Parry S.J.
        • Stern J.S.
        • et al.
        Redundant parasympathetic and sympathoadrenal mediation of increased glucagon secretion during insulin-induced hypoglycemia in conscious rats.
        Metabolism. 1994; 43: 860-866
        • Havel P.J.
        • Valverde C.
        Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys.
        Diabetes. 1996; 45: 960-966
        • Havel P.J.
        • Ahren B.
        Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women.
        Diabetes. 1997; 46: 801-807
        • Havel P.J.
        • Veith R.C.
        • Dunning B.E.
        • et al.
        Role for autonomic nervous system to increase pancreatic glucagon secretion during marked insulin-induced hypoglycemia in dogs.
        Diabetes. 1991; 40: 1107-1114
        • Cryer P.E.
        Mechanisms of Hypoglycemia-Associated Autonomic Failure in Diabetes.
        N Engl J Med. 2013; 369: 362-372
        • Boyle P.J.
        • Schwartz N.S.
        • Shah S.D.
        • et al.
        Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics.
        N Engl J Med. 1988; 318: 1487-1492
        • Amiel S.A.
        • Sherwin R.S.
        • Simonson D.C.
        • et al.
        Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
        Diabetes. 1988; 37: 901-907
        • Brownlee M.
        Biochemistry and molecular cell biology of diabetic complications.
        Nature. 2001; 414: 813-820
        • Mundinger T.O.
        • Cooper E.
        • Coleman M.P.
        • et al.
        Short-term diabetic hyperglycemia suppresses celiac ganglia neurotransmission, thereby impairing sympathetically mediated glucagon responses.
        Am J Physiol Endocrinol Metab. 2015; 309: E246-E255
        • Heller S.R.
        • Cryer P.E.
        Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans.
        Diabetes. 1991; 40: 223-226
        • Lontchi-Yimagou E.
        • You J.Y.
        • Carey M.
        • et al.
        Potential approaches to prevent hypoglycemia-associated autonomic failure.
        J Investig Med. 2018; 66: 641-647
        • Davis S.N.
        • Tate D.
        • Hedrington M.S.
        Mechanisms of hypoglycemia and exercise-associated autonomic dysfunction.
        Trans Am Clin Climatol Assoc. 2014; 125 (discussion 291-2): 281-291
        • Seaquist E.R.
        • Moheet A.
        • Kumar A.
        • et al.
        Hypothalamic Glucose Transport in Humans During Experimentally Induced Hypoglycemia-Associated Autonomic Failure.
        J Clin Endocrinol Metab. 2017; 102: 3571-3580
        • Moheet A.
        • Kumar A.
        • Eberly L.E.
        • et al.
        Hypoglycemia-associated autonomic failure in healthy humans: comparison of two vs three periods of hypoglycemia on hypoglycemia-induced counterregulatory and symptom response 5 days later.
        J Clin Endocrinol Metab. 2014; 99: 664-670
        • Geddes J.
        • Schopman J.E.
        • Zammitt N.N.
        • et al.
        Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes.
        Diabet Med. 2008; 25: 501-504
        • Schopman J.E.
        • Geddes J.
        • Frier B.M.
        Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes.
        Diabetes Res Clin Pract. 2010; 87: 64-68
        • Gilor C.
        • Duesberg C.
        • Elliott D.A.
        • et al.
        Co-impairment of autonomic and glucagon responses to insulin-induced hypoglycemia in dogs with naturally occurring insulin-dependent diabetes mellitus.
        Am J Physiol Endocrinol Metab. 2020; 319: E1074-E1083
        • Mundinger T.O.
        • Taborsky G.J.
        Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation.
        Diabetologia. 2016; 59: 2058-2067
        • Taborsky G.J.
        • Mei Q.
        • Bornfeldt K.E.
        • et al.
        The p75 neurotrophin receptor is required for the major loss of sympathetic nerves from islets under autoimmune attack.
        Diabetes. 2014; 63: 2369-2379
        • Taborsky G.J.
        • Mei Q.
        • Hackney D.J.
        • et al.
        Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis.
        Diabetologia. 2009; 52: 2602-2611
        • Mei Q.
        • Mundinger T.O.
        • Lernmark A.
        • et al.
        Early, selective, and marked loss of sympathetic nerves from the islets of BioBreeder diabetic rats.
        Diabetes. 2002; 51: 2997-3002
        • Mundinger T.O.
        • Mei Q.
        • Figlewicz D.P.
        • et al.
        Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy.
        Am J Physiol Endocrinol Metab. 2003; 285: E1047-E1054
        • Mundinger T.O.
        • Mei Q.
        • Foulis A.K.
        • et al.
        Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves.
        Diabetes. 2016; 65: 2322-2330
        • Gilor C.
        • Pires J.
        • Greathouse R.
        • et al.
        Loss of sympathetic innervation to islets of Langerhans in canine diabetes and pancreatitis is not associated with insulitis.
        Sci Rep. 2020; 10: 19187
        • SOMOGYI M.
        Exacerbation of diabetes by excess insulin action.
        Am J Med. 1959; 26: 169-191
        • Rybicka M.
        • Krysiak R.
        • Okopień B.
        The dawn phenomenon and the Somogyi effect - two phenomena of morning hyperglycaemia.
        Endokrynol Pol. 2011; 62: 276-284
        • Matyka K.A.
        • Crowne E.C.
        • Havel P.J.
        • et al.
        Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
        Diabetes Care. 1999; 22: 1144-1150
        • Guillod L.
        • Comte-Perret S.
        • Monbaron D.
        • et al.
        Nocturnal hypoglycaemias in type 1 diabetic patients: what can we learn with continuous glucose monitoring?.
        Diabetes Metab. 2007; 33: 360-365
        • Choudhary P.
        • Davies C.
        • Emery C.J.
        • et al.
        Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?.
        Diabet Med. 2013; 30: 914-917
        • Høi-Hansen T.
        • Pedersen-Bjergaard U.
        • Thorsteinsson B.
        The Somogyi phenomenon revisited using continuous glucose monitoring in daily life.
        Diabetologia. 2005; 48: 2437-2438
        • Gehlaut R.R.
        • Dogbey G.Y.
        • Schwartz F.L.
        • et al.
        Hypoglycemia in Type 2 Diabetes--More Common Than You Think: A Continuous Glucose Monitoring Study.
        J Diabetes Sci Technol. 2015; 9: 999-1005
        • Klimontov V v
        • Myakina N.E.
        Glucose variability indices predict the episodes of nocturnal hypoglycemia in elderly type 2 diabetic patients treated with insulin.
        Diabetes Metab Syndr. 2017; 11: 119-124
        • Fanelli C.G.
        • Porcellati F.
        • Pampanelli S.
        • et al.
        Insulin therapy and hypoglycaemia: the size of the problem.
        Diabetes Metab Res Rev. 2004; 20: S32-S42
        • Feldman E.C.
        • Nelson R.W.
        Insulin-induced hyperglycemia in diabetic dogs.
        J Am Vet Med Assoc. 1982; 180: 1432-1437
        • McMillan F.D.
        • Feldman E.C.
        Rebound hyperglycemia following overdosing of insulin in cats with diabetes mellitus.
        J Am Vet Med Assoc. 1986; 188: 1426-1431
        • Reusch Claudia
        Feline diabetes mellitus.
        in: Feldman E. Nelson R.W. Canine and feline endocrinology. 4th edition. Saunders, St. Louis, MO2015: 258-308